Moderna asks FDA to evaluate its COVID-19 vaccine for booster shot
CBSN
Moderna said on Wednesday it is asking the Food and Drug Administration to evaluate its COVID-19 vaccine for use in a booster shot. The drugmaker's own testing found that a third shot created "robust antibody responses" to the Delta variant, which is spreading across the U.S.
Moderna also plans to submit data to the European Medicines Agency and other regulatory authorities around the world in the next few days. The biotech company's submission the FDA comes as the Biden administration recommends that most Americans get a booster shot eight months after their second dose of a COVID-19 vaccine. Once the vaccines are fully approved by the FDA and signed off by the Centers for Disease Control and Prevention, the boosters could be administered.Two Native Hawaiian brothers who were convicted in the 1991 killing of a woman visiting Hawaii allege in a federal lawsuit that local police framed them "under immense pressure to solve the high-profile murder" then botched an investigation last year that would have revealed the real killer using advancements in DNA technology.
In one of his first acts after returning to the Oval Office this week, President Trump tasked federal agencies with developing ways to potentially ease prices for U.S. consumers. But experts warn that his administration's crackdown on immigration could both drive up inflation as well as hurt a range of businesses by shrinking the nation's workforce.
Meta is denying claims circulating on social media that it forced Facebook and Instagram users to follow President Trump's official accounts, saying the changes some users noticed were standard practices tied to the transition of the POTUS account from the previous administration to the incoming one.